XENE

XENON PHARMACEUTICALS INC

XENE·98420N105·US·Common Stock·Healthcare - Biotechnology-13D/G

XENE (XENON PHARMACEUTICALS INC) is held by 153 institutional investors as of Q1 2026. Largest holders: FMR LLC ($629.1M), Avoro Capital Advisors LLC ($336M), BlackRock, Inc. ($328M). Net institutional sentiment: Bullish.

153
Holders
(25 Elite)
$4.6B
Total Value
71% (156)
Consensus
110 buying - 46 selling
13F: Insider & Congress:
XENESmart Money Verdict
View all
Held by 153 funds
25 elite
Who's Trading
ActivistDRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC4.9%May 15, 2026
ActivistAvoro Capital Advisors LLCAvoro Capital Advisors LLC6.3%May 15, 2026
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC4.5%May 15, 2026
InsiderMIMORTIMER IANSell $404KMar 13, 2026
InsiderDADiFabio AndreaSell $74KMar 13, 2026
InsiderKJKENNEY CHRISTOPHER JOHNSell $78KMar 13, 2026
InsiderMIMORTIMER IANSell $677KMar 10, 2026
InsiderDADiFabio AndreaSell $157KMar 10, 2026
InsiderKJKENNEY CHRISTOPHER JOHNSell $167KMar 10, 2026
InsiderMIMORTIMER IANSell $2.6MMar 9, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
10.8M(+21.3%)$629.1M0.0%+77.55%
38
Increased
5.8M(+6.5%)$336M3.3%+201.61%
62
Increased
5.6M(+10.6%)$328M0.0%+90.69%
34
Increased
4.8M(+1.4%)$280.8M0.1%+65.46%
31
Decreased
4.5M(-1.0%)$261.2M1.9%+138.68%
0
Increased
4.4M(+78.7%)$256.2M0.9%+81.42%
66
Increased
4.2M(+2.3%)$242.9M0.1%+78.37%
38
Decreased
2.7M(-21.7%)$155.5M0.0%+144.33%
0
Increased
2.7M(+100.8%)$154.3M0.0%+64.35%
49
Increased
1.9M(+28.8%)$106.9M0.0%+72.22%
38
Increased
1.7M(+15.3%)$100M0.0%+88.80%
34
Increased
1.5M(+18.4%)$88.3M0.2%+98.90%
42
Increased
1.4M(+14.2%)$81.5M0.3%+71.74%
41
Increased
1.3M(+26.6%)$78M0.1%+62.30%
37
Increased
1.3M(+54.2%)$77.3M0.0%+57.87%
42
Increased
1.3M(+2.1%)$76.7M0.1%+67.54%
30
New
1.3M$75.6M0.2%+57.39%
49
Increased
1.3M(+68.9%)$74.5M0.0%+67.57%
44
Increased
1.1M(+14.7%)$63.5M0.0%+104.89%
34
Decreased
1.4M(-11.9%)$62.9M0.0%+85.51%
0

Showing 1-20 of 164

1 / 9

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used